Wizcure Pharmaa Recalls Eye Drops Due to Sterility Risk
Wizcure Pharmaa PVT. LTD. recalled 11,520 cartons of Vista Meibo Tears Eye Drops on December 31, 2025. The recall occurred due to lack of assurance of sterility, posing a high risk to consumers. The affected product was distributed nationwide in the USA.
About This Product
Vista Meibo Tears eye drops are used for the relief of dry eyes, providing lubrication to alleviate discomfort. Consumers typically purchase these drops to manage symptoms of dryness due to various environmental factors or prolonged screen time.
Why This Is Dangerous
The lack of assurance of sterility can lead to contamination, potentially resulting in serious eye infections that could affect vision and overall eye health.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers who have used the affected eye drops may face health risks, prompting immediate discontinuation and consultation with healthcare providers.
Practical Guidance
How to identify if yours is affected
- Check the product label for Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops.
- Verify the lot number against the recall notice.
- If unsure, consult with a pharmacist or healthcare provider.
Where to find product info
Look for the lot number on the outer packaging or the bottle label.
What timeline to expect
Expect a refund or replacement within 4-6 weeks after processing your request.
If the manufacturer is unresponsive
- Document all communication attempts with Wizcure Pharmaa.
- Contact the FDA or consumer protection agencies for further assistance.
- Consider seeking legal advice if health issues arise.
How to prevent similar issues
- Always check for recalls before purchasing eye care products.
- Look for products that are labeled as sterile or preservative-free.
- Consult with an eye care professional for recommendations.
Documentation advice
Keep receipts, lot numbers, and any correspondence with the manufacturer for your records.